Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Glutamine for Vincristine-Induced Neuropathy in Pediatric Cancer
NCT00365768Phase 2Completed
- Sponsor
- Columbia University
- Start
- Oct 2004
- Primary completion
- Jun 2012
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in peripheral neuropathy comparing Glutamine with Placebo (2 arms). Primary endpoint: Incidence of Vincristine-induced Peripheral Neuropathy at 30 weeks. Started Oct 2004; status: completed.
02
Drugs
glutamine
03
Conditions
peripheral neuropathy
Beyond the preview
Go deeper on NCT00365768.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00365768.